Reduced consumption of antiinflammatory and analgesic agents in the treatment of chronic neuropathic pain in patients affected by compression-causing lumbosciatic pain and treated with Normast® 300 mg;Reducción del consumo de antiinflamatorios y analgésicos en el tratamiento del dolor neuropático crónico en pacientes afectados por lumbociatalgia de tipo compresivo y en tratamiento con Normast® 300 mg

DOLOR

Volumn 25, Issue 4, 2010, Pages 227-234

  Canteri, L ^a   Petrosino, S ^b   Guida, G ^c  

^a Hospital de Montebelluna   (Italy)

^b Hospital de Pescopagano   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

AINE; Chronic neuropathic pain; Lumbosciatic pain; Nerve root compression

Indexed keywords

ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; NORMAST; PLACEBO; UNCLASSIFIED DRUG;

ARTICLE; CHRONIC PAIN; CLINICAL PROTOCOL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG USE; FEMALE; HUMAN; ISCHIALGIA; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NERVE ROOT COMPRESSION; NEUROPATHIC PAIN; PERIPHERAL NEUROPATHY; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; VISUAL ANALOG SCALE;

EID: 79952554794     PISSN: 02140659     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Chou R, Qaseem A, Snow V, et al. Clinical Efficacy Assessment Subcommittee of the American College of Physicians; American College of Physicians; American Pain Society Low Back Pain Guidelines Panel. Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern Med. 2007;147(7):478-91.
2. Chou R, Huffman LH; American Pain Society; American College of Physicians. Medications for acute and chronic low back pain: a review of the evidence for an American Pain Society / American College of Physicians clinical practice guideline. Ann Intern Med. 2007;147(7):505-14.
3. Chou R, Huffman LH; American Rain Society; American College of Physicians. Nonpharmacologic therapies for acute and chronic low back pain: a review of the evidence for an American Pain Society / American College of Physicians clinical practice guideline. Ann Intern Med. 2007;147(7):492-504.
4. Kong VK, Irwin MG. Adjuvant analgesics in neuropathic pain. Eur J Anaesthesiol. 2009;26(2):96-100.
5. Calignano A, La Rana G, Giuffrida A, Piomelli D. Control of pain initiation by endogenous cannabinoids. Nature (London). 1998;394: 277-81. (Pubitemid 28335039)
6. Calignano A, La Rana G, Piomelli D. Antinociceptive activity of (he endogenous fatty acid amide, palmitylethanolamide. Eur J Pharmacol. 2001;419;191-8.
7. Lambert DM, Vandevoorde S, Jonsson KO, Fowler CJ. The palmitoylethanolamide family: a new class of anti-inflammatory agents? Curr Med Chem. 2002;9:663-74.
8. Costa B, Comelli F, Bettoni I, Colleoni M, Giagnoni G. The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and anti-hyperalgesic effects in a murine model of neuropathic pain: involvement of CB(1), TRPV1 and PPARgamma receptors and neutrophic factors. Pain. 2008;139:541-50.
9. Sokal DM, Elmes SJ, Kendall DA, Chapman V. Intraplantar injection of anandamide inhibits mechanically-evoked responses of spinal neurones via activation of CB2 receptors in anaesthetised rats. Neuropharmacology. 2003;45(3):404-11. (Pubitemid 36836136)
10. Horvath G. Kekesi G, Nagy L. Benedek G. The role of TRPV1 receptors in the antinociceptive effect of anandamide at spinal level. Pain. 2007;134:277-84.
11. Mazzari S, Canella R, Petrelli L, Marcolongo G, Leon A. N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation. Eur J Pharmacol. 1996;300(3):227-36.
12. Aloe L, Leon A, Levi-Montalcini RA. Proposed autoacoid mechanism controlling mastocyte behaviour. Agents Actions. 1993;39 Spec No: C145-7.
13. Facci L, Dal Toso R, Romanello S, Buriani A, Skaper SD, Leon A. Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoyl ehanolamide. Proc Natl Acad Sci U.S.A. 1995;92(8):3376-80.
14. De Filippis D, D'Amico A, Cinelli MP, Esposito G, Di Marzo V, Iuvone T. Adelmidrol, a palmitoylethanolamide analog, reduces chronic inflammation in a carrageenan granuloma model in rats. J Cell Mol Med. 2008 A. [Epub ahead of print].
15. Guida G, De Martino M, De Fabiani A, et al. La palmitoiletanolamide (NORMAST®) nel dolore neuropatico cronico da lombosciatalgia di tipo compressivo: studio clinico multicentrico. (2006. Data on file).
16. Suter MR, Wen YR, Decosterd I, Ji RR. Do glial celles control pain? Neuron Glia Biol. 2007;3(3):255-68.
17. Petrosino S, Palazzo E, de Novellis V, et al. Changes in spinal and supraspinal endonnabinoid levels in neuropathic rats. Neuropharmacology. 2007;52:415-22. (Pubitemid 46127787)